Effect of Celecoxib Combined With Low-Dose-Rate Brachytherapy on Long-Term Oncological Outcomes and Quality of Life in Prostate Cancer: Post Hoc Analysis of an Open-Label Controlled Randomized Trial.
Key Points
To evaluate the effects of celecoxib combined with low-dose-rate brachytherapy on oncological outcomes and quality of life in prostate cancer.
Post hoc analysis of an open-label controlled randomized trial
Evaluation of long-term oncological outcomes
Assessment of quality of life indicators
Improvement in long-term oncological outcomes with the combination treatment
Enhanced quality of life reported among participants receiving celecoxib and brachytherapy
Abstract
Umin000003649.
Like
Bookmark
Share
Like
Bookmark
Share
Effect of Celecoxib Combined With Low-Dose-Rate Brachytherapy on Long-Term Oncological Outcomes and Quality of Life in Prostate Cancer: Post Hoc Analysis of an Open-Label Controlled Randomized Trial. | Synapse